Evidence map›Paper›PMID 31552007›Full record

ArticleFrontiers in microbiology2019

Experimental Evidence for Limited

Baltazar Cá, Kaori L Fonseca, Jeremy Sousa, Ana Raquel Maceiras, Diana Machado, Lilica Sanca, Paulo Rabna, Pedro N S Rodrigues, Miguel Viveiros, Margarida Saraiva

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Heliyon · 2023
    Article
  6. Review
  7. Article
  8. Understanding the Genetic Diversity ofFrontiers in genetics · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Baltazar Cái3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
Kaori L Fonsecai3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
Jeremy Sousai3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
Ana Raquel Maceirasi3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
Diana MachadoGlobal Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Lilica SancaInstituto Nacional de Saúde Pública/Projeto de Saúde de Bandim, Bissau, Guinea-Bissau.
Paulo RabnaInstituto Nacional de Saúde Pública/Projeto de Saúde de Bandim, Bissau, Guinea-Bissau.
Pedro N S Rodriguesi3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
Miguel ViveirosGlobal Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Margarida Saraivai3S - Instituto de Investigação e Inovação em Saúde, Porto, Portugal.
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTInstituto Gulbenkian de Ciência · PTUniversidade Nova de Lisboa · PTUniversidade do Porto · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis remains a public health problem and a main cause of death to humans. Both

Indexed as

cytokinesimmune responseMycobacterium africanumpathologytuberculosis

Identifiers

PMID31552007
PMCPMC6746983
OpenAlexW2971283980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.